Related Experiment Video
Updated: Aug 10, 2026
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Prodromal bullous pemphigoid
Philina M Lamb1, Edward Abell, Michael Tharp
1Department of Dermatology, University of Pittsburgh School of Medicine, PA 15240, USA.
Background:
Prodromal bullous pemphigoid (PBP) can be difficult to diagnose. Early recognition in its early stages may decrease the morbidity and progression of the disease. Clinical presentations and current treatments available for PBP will be described.
Methods:
A retrospective review was performed on 53 patients diagnosed with PBP.
Results:
Overall, the average disease duration of PBP was 11.8 months. The average age of presentation of PBP was 70.8 years. The most common presentations were urticaria-like plaques (67.9%), eczema-like lesions (11.3%), and dermatitis herpetiformis-like lesions (9.4%). The majority of patients responded well to low doses of systemic corticosteroids, tetracycline, and/or high potency topical corticosteroids.
Conclusions:
Patients with PBP tend to be in their sixth or early seventh decade of life and, on average, the duration of disease is 1 year. The most common presentation of disease is urticaria-like plaques.
Related Concept Videos
01:24Smallpox
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
01:30Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...